HUE064946T2 - Benzimidazolt tartalmazó gyógyászati készítmény - Google Patents

Benzimidazolt tartalmazó gyógyászati készítmény

Info

Publication number
HUE064946T2
HUE064946T2 HUE20720419A HUE20720419A HUE064946T2 HU E064946 T2 HUE064946 T2 HU E064946T2 HU E20720419 A HUE20720419 A HU E20720419A HU E20720419 A HUE20720419 A HU E20720419A HU E064946 T2 HUE064946 T2 HU E064946T2
Authority
HU
Hungary
Prior art keywords
benzimidazole
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
HUE20720419A
Other languages
English (en)
Inventor
Ljiljana Krsteska
Elena Kazandzievska
Andrew Willis
Original Assignee
Alkaloid Ad Skopje
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkaloid Ad Skopje filed Critical Alkaloid Ad Skopje
Publication of HUE064946T2 publication Critical patent/HUE064946T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE20720419A 2019-05-08 2020-04-17 Benzimidazolt tartalmazó gyógyászati készítmény HUE064946T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1906473.2A GB2585628A (en) 2019-05-08 2019-05-08 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
HUE064946T2 true HUE064946T2 (hu) 2024-04-28

Family

ID=67384781

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE20720419A HUE064946T2 (hu) 2019-05-08 2020-04-17 Benzimidazolt tartalmazó gyógyászati készítmény

Country Status (10)

Country Link
US (1) US20230172918A1 (hu)
EP (1) EP3965735B1 (hu)
CN (2) CN117731663A (hu)
CA (1) CA3155076C (hu)
EA (1) EA202193059A1 (hu)
ES (1) ES2958972T3 (hu)
GB (1) GB2585628A (hu)
HU (1) HUE064946T2 (hu)
UA (1) UA127653C2 (hu)
WO (1) WO2020224936A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2616663A (en) * 2022-03-18 2023-09-20 Alkaloid Ad Skopje Pharmaceutical formulation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284249B6 (cs) * 1992-07-28 1998-10-14 Astra Aktiebolag Injekce a injekční souprava obsahující omeprazol a jeho analogy
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
AUPS290502A0 (en) * 2002-06-12 2002-07-04 Gannon, Glen Charles A drink container for combining a powder with a liquid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CN101600432A (zh) * 2006-10-27 2009-12-09 密苏里大学董事会 包含至少一种对酸敏感的质子泵抑制剂、任选其它药物活性剂的组合物以及使用它们的方法
US20110129433A1 (en) * 2008-06-26 2011-06-02 Ironwood Pharmaceuticals, Inc. Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders
IN2012DN00359A (hu) * 2009-07-20 2015-05-22 Vetegen Llc
CN102078616A (zh) * 2011-01-28 2011-06-01 北京虹湾医药技术有限公司 埃索美拉唑碳酸氢钠组合物
CN107260691A (zh) * 2017-08-08 2017-10-20 湖南科伦制药有限公司 一种奥美拉唑钠冻干粉针剂的制备方法
CN108785259A (zh) * 2017-12-27 2018-11-13 成都国为生物医药有限公司 一种含有艾司奥美拉唑钠的药物组合物及其制备方法

Also Published As

Publication number Publication date
EP3965735B1 (en) 2023-08-30
WO2020224936A1 (en) 2020-11-12
GB201906473D0 (en) 2019-06-19
CN117731663A (zh) 2024-03-22
CA3155076A1 (en) 2020-11-12
CA3155076C (en) 2024-01-02
US20230172918A1 (en) 2023-06-08
GB2585628A (en) 2021-01-20
EP3965735C0 (en) 2023-08-30
UA127653C2 (uk) 2023-11-15
CN113727702A (zh) 2021-11-30
EA202193059A1 (ru) 2022-03-05
ES2958972T3 (es) 2024-02-16
EP3965735A1 (en) 2022-03-16

Similar Documents

Publication Publication Date Title
GB2576059B (en) A pharmaceutical formulation comprising psilocybin
GB201807942D0 (en) Pharmaceutical formulation
IL271226A (en) medical preparation
ZA202102871B (en) Pharmaceutical formulation
ZA202006570B (en) Pharmaceutical formulations
IL285674A (en) Pharmaceutical formulations
SG11202010124SA (en) Stable pharmaceutical formulation
IL278927A (en) pharmaceutical preparation
IL273704A (en) Pharmaceutical bilayer tablet formulations
IL290894A (en) pharmaceutical preparation
FI3601277T3 (fi) Farmaseuttinen formulaatio
GB202010230D0 (en) Pharmaceutical formulation
HUE064946T2 (hu) Benzimidazolt tartalmazó gyógyászati készítmény
IL297081A (en) Pharmaceutical formulation
GB201910787D0 (en) Pharmaceutical development
IL275144A (en) Pharmacy preparation
HUE064434T2 (hu) Gyógyászati készítmény
SG10201912063PA (en) A pharmaceutical formulation
IL289927A (en) A new pharmaceutical formulation
IL297080A (en) Pharmaceutical formulation
GB202100526D0 (en) Pharmaceutical formulation
GB201916808D0 (en) Pharmaceutical delivery device
EP4061369A4 (en) PHARMACEUTICAL FORM COMPRISING AN ACIDIC SUBSTANCE
GB201917327D0 (en) New pharmaceutical use
GB201913328D0 (en) New Pharmaceutical use